The title compound was synthesized by N-alkylation of 4-(4-chlorophenyl)piperazine with ethyl 2-bromo-2-methylpropanoate and its IR, 1 H NMR, 13 C NMR and Mass spectroscopic data are reported.
One of the principal interests of our research group is to design and synthesize candidate cytotoxins based on the α,β-unsaturated keto scaffolds [1] [2] [3] . A number of these molecules have been shown to alkylate thiols but not amino or hydroxy substituents. Since thiols, in contrast to amino or hydroxyl groups are not found in nucleic acids, α,β-unsaturated ketones are bereft of the carcinogenic and mutagenic properties displayed by various anticancer drugs [4] . A series of compounds, including the title compound 2-[4-(4-chlorophenyl)-piperazin-1-yl]-2-methylpropanoic acid ethyl ester (3) were prepared for the construction of somewhat complex molecules containing α,β-unsaturated keto scaffold. The title compound was prepared by the route depicted in the scheme below.
To a solution of 4-(4-chlorophenyl)piperazine dihydrochloride 1 (5.0 g, 0.0185 mol) in DMSO (30 ml), anhydrous cesium carbonate (30.0 g, 0.0925 mol), sodium iodide (1.39 g, 0.0093 mol) and ethyl 2-bromo-2-methylpropanoate 2 (3.97 g, 0.02 mol) were added. The resulting mixture was stirred at 25-30 o C for 12 hours. The reaction mass was diluted with water (200 ml) and extracted with ethyl acetate (2 x 200 ml). The ethyl acetate layer was washed with water (2 x 100 ml), dried over 
